Foods to improve sleep
A food composition combining cannabidiol with vitamins, amino acids, and minerals enhances the sleep-inducing effects of cannabidiol, addressing the lack of synergistic formulations in existing foods to improve sleep disorders effectively.
Patent Information
- Application Number
- JP2023553144
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-10-25
- Filing Date
- 2022-10-25
- Publication Date
- 2024-11-13
- Estimated Expiration
- 2042-10-25
AI Technical Summary
Existing compositions do not effectively promote the sleep disorder-improving effect of cannabidiol and are not formulated to synergistically enhance its physiological effects when incorporated into foods.
A food composition containing cannabidiol with a sleep induction auxiliary composition comprising vitamins (such as vitamin B6), amino acids (like γ-aminobutyric acid and taurine), and minerals (such as calcium) in specific ratios, formulated to enhance the sleep-inducing effects of cannabidiol.
The synergistic combination of cannabidiol with vitamins, amino acids, and minerals significantly promotes the sleep disorder-improving effect, providing a reliable and steady improvement in sleep onset.
Smart Images

Figure 0007582718000007 
Figure 0007582718000008 
Figure 0007582718000009
Abstract
Description
[Technical field]
[0001] The present invention relates to a food for improving sleep. [Background technology]
[0002] Cannabidiol, contained in hemp, has traditionally been known as a substance useful for treating multiple sclerosis, neuropathic pain, cancer, arteriosclerosis, obesity, metabolic syndrome, and diabetes.
[0003] Although cannabidiol is a cannabinoid, unlike tetrahydrocannabinol, which is known as a psychotropic drug, it does not have euphoric or euphoric effects and has not been shown to be abused, dependent or prone to tolerance, so in recent years it has been incorporated into a variety of medicines and health foods.
[0004] As a specific example, a health food having antitumor and antiallergic effects that combines oil containing cannabidiol with fucoidan has been proposed (see, for example, Patent Document 1). [Prior art documents] [Patent documents]
[0005] [Patent Document 1] JP 2017-079615 A Summary of the Invention [Problem to be solved by the invention]
[0006] In addition to the various effects mentioned above, cannabidiol is also known to have the effect of improving sleep disorders.
[0007] However, no composition has yet been proposed that can further enhance the sleep disorder improving effect of cannabidiol, nor a composition composed of ingredients that can be added to food.
[0008] The present invention has been made in consideration of the above circumstances, and provides a food for improving sleep that contains a sleep-inducing auxiliary composition that enhances the sleep disorder improving effect of cannabidiol. [Means for solving the problem]
[0009] In order to solve the above-mentioned problems, the food for improving sleep according to the present invention is a food for improving sleep, which comprises: (1) cannabidiol and a sleep-inducing composition that promotes the sleep disorder improving effect of the cannabidiol, and the sleep-inducing composition is composed of vitamins, amino acids, and minerals. ,before The vitamin is contained in an amount of 0.1 to 10 parts by weight per 100 parts by weight of the food for improving sleep. Ta Vitamin B6 and The amino acid is a first amino acid which is γ-aminobutyric acid and is contained in 5 to 20 parts by weight in 100 parts by weight of the food for improving sleep, and tauricin. In and a second amino acid, the second amino acid being contained in an amount of 0.1 to 12 parts by weight per 100 parts by weight of the food for improving sleep, and the mineral is contained in an amount of 0.2 to 15 parts by weight per 100 parts by weight of the food for improving sleep. Ta Calcium In It was decided that there was.
[0010] The sleep-improving food according to the present invention also has the following features. ( 2 ) The cannabidiol is contained in an amount of 0.05 to 10 parts by weight per 100 parts by weight of the food for improving sleep. ( 3 ) The dosage form is powder, fine granules, granules, soft capsules, hard capsules, jelly, gummy candy, liquid or tablet. Effect of the Invention
[0011] According to the food for improving sleep of the present invention, the food for improving sleep contains cannabidiol and a sleep-inducing auxiliary composition that promotes the sleep disorder improving effect of the cannabidiol, and the sleep-inducing auxiliary composition is composed of vitamins, amino acids and minerals, so it is possible to provide a food for improving sleep that contains a sleep-inducing auxiliary composition that promotes the sleep disorder improving effect of cannabidiol.
[0012] Furthermore, if the cannabidiol is contained in an amount of 0.05 to 10 parts by weight in 100 parts by weight of the food for improving sleep, the sleep disorder improving effect derived from cannabidiol can be enjoyed more reliably.
[0013] Furthermore, if the vitamin contains at least one selected from vitamin B1, vitamin B6, vitamin B12, vitamin D, and folic acid, the effect of improving sleep disorders can be more significantly promoted compared to when only vitamins other than these are included as components of the sleep-inducing composition.
[0014] Furthermore, if the vitamin is contained in an amount of 0.1 to 10 parts by weight in 100 parts by weight of the food for improving sleep, the effect of improving sleep disorders can be promoted more reliably.
[0015] Furthermore, when the amino acid contains both a first amino acid which is γ-aminobutyric acid and a second amino acid which is at least one selected from taurine, leucine, phenylalanine, methionine, lysine, glycine, cysteine, and serine, the effect of improving sleep disorders can be more significantly promoted compared to a case in which the first and second amino acids are not used in combination.
[0016] Furthermore, if 100 parts by weight of the food for improving sleep include 5 to 20 parts by weight of the first amino acid and 0.1 to 12 parts by weight of the second amino acid, the effect of improving sleep disorders can be promoted more reliably.
[0017] Furthermore, if the mineral is at least one selected from potassium, calcium, magnesium, iron, and zinc, the effect of improving sleep disorders can be more significantly promoted compared to when only minerals other than these are included as components of the sleep-inducing composition.
[0018] Furthermore, if the mineral is contained in an amount of 0.2 to 15 parts by weight in 100 parts by weight of the food for improving sleep, the effect of improving sleep disorders can be promoted more reliably.
[0019] Furthermore, by making the dosage form into powder, fine granules, granules, soft capsules, hard capsules, jelly, gummy candy, liquid or tablet, the sleep-improving food can be ingested in a dosage form appropriate for people of all ages, from young people to the elderly. [Brief description of the drawings]
[0020] [Figure 1] 1 is a graph showing the results of a test to verify the effectiveness of foods for improving sleep. [Diagram 2] 1 is a graph showing the results of a test to verify the effectiveness of foods for improving sleep. [Diagram 3] 1 is a graph showing the results of a test to verify the effectiveness of foods for improving sleep. [Figure 4] 1 is a graph showing the results of a test to verify the effectiveness of foods for improving sleep. [Diagram 5] 1 is a graph showing the results of a test to verify the effectiveness of foods for improving sleep. [Figure 6] 1 is a graph showing the results of a test to verify the effectiveness of foods for improving sleep. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0021] The present invention relates to a food for improving sleep onset, and in particular to a food for improving sleep onset that contains cannabidiol and a sleep-inducing auxiliary composition that enhances the effect of cannabidiol in improving sleep disorders.
[0022] It has been known through pharmaceutical and clinical research that cannabidiol (CBD), which is extracted from hemp seeds or hemp stems, has beneficial effects against mental and physical disorders.
[0023] Because cannabidiol is an ingredient extracted from the seeds and stems of mature cannabis plants (Cannabis sativa L.), it has tended to be misunderstood in Japan from the perspective of the Cannabis Control Act and therefore avoided as an ingredient in food products.
[0024] However, cannabidiol is completely different from the so-called "marijuana or cannabis" that has a stimulant effect as defined by the Cannabis Control Act. "Cannabis" as defined by the Cannabis Control Act means the inflorescence and leaves of the annual cannabis plant, or a compound with 21 carbon atoms that is derived from them. A representative example of such an ingredient is tetrahydrocannabinol (THC), the main ingredient of marijuana.
[0025] In other words, the cannabidiol used in the present invention is a component that is completely different from tetrahydrocannabinol in both structure and physiological action, and is a safe polyphenol structure obtained from the seeds or stems of mature industrial cannabis plants that does not have the stimulant or psychoactive effects of marijuana.
[0026] Cannabidiol is also known pharmacologically and clinically to act on cannabidiol receptors throughout the body and exert a variety of useful effects, and is considered to be particularly useful for treating mental and physical disorders such as anxiety, depression, insomnia, schizophrenia, and various neurological disorders.
[0027] Therefore, cannabidiol has already been incorporated into cosmetics and processed foods and commercialized in Japan.
[0028] However, conventionally known foods containing cannabidiol are specialized in the effects of the single ingredient cannabidiol, and are not formulated from a synergistic perspective to utilize the biological and physiological effects that cannabidiol originally possesses.
[0029] In other words, the physiological effects of cannabidiol promote the physiological functions that living organisms naturally possess, and when commercializing cannabidiol preparations, it is important to design the formulation taking into consideration the promotion of physiological metabolism, such as promoting metabolism, regulating the synaptic potential of the nervous system, and promoting neurotransmission in the brain.
[0030] Originally, cannabidiol is a component that has the function of promoting and regulating biologically active functions, and has a so-called triggering mechanism of action that acts on physiologically active substances such as metabolic enzymes, neurotransmitter functions, metabolic functions, and hormones present in the living body.
[0031] Therefore, the physiological effects that can be expected from taking cannabidiol alone are extremely limited, and it can be said that in order to achieve the aforementioned beneficial effects, it is more effective to use it in combination with a synergistic ingredient.
[0032] In particular, when formulating a drug to improve insomnia, the desired effect cannot be expected unless it acts on the cannabinoid receptors (CB1, CB2) scattered throughout the central nervous system, cerebral cortex, hippocampus, cerebellum, brain stem, basal ganglia, hypothalamus, etc., which is the original mechanism of action of cannabidiol.
[0033] In this regard, the food for improving sleep in this embodiment is a combination of cannabidiol and a sleep-inducing aid composition that enhances the sleep disorder improving effect of cannabidiol, thereby aiming to create a food for improving sleep that can enhance the sleep disorder improving effect of cannabidiol.
[0034] Moreover, the sleep-inducing composition, which is one of the features of the food for improving sleep according to this embodiment, is made up of vitamins, amino acids, and minerals. In other words, since all of the components of the sleep-inducing composition are food ingredients, it is possible to improve sleep onset as part of daily dietary habits.
[0035] Cannabidiol is preferably contained in a proportion of 0.05 to 10 parts by weight per 100 parts by weight of the food for improving sleep. By containing cannabidiol at such a concentration, the sleep disorder improving effect derived from cannabidiol can be enjoyed more reliably.
[0036] The vitamin constituting the sleep-inducing aid composition may contain at least one selected from vitamin B1, vitamin B6, vitamin B12, vitamin D, and folic acid.
[0037] The vitamins are preferably contained in an amount of 0.1 to 10 parts by weight per 100 parts by weight of the food for improving sleep. By including vitamins in such a concentration, the vitamins can function together with amino acids and minerals, which are the other components of the sleep-inducing aid composition, to steadily promote the sleep disorder improving effect of cannabidiol.
[0038] Furthermore, the amino acids constituting the sleep-inducing composition are composed of a first amino acid and a second amino acid, and it is desirable for 100 parts by weight of the food for improving sleep to contain 5 to 20 parts by weight of the first amino acid and 0.1 to 12 parts by weight of the second amino acid.
[0039] The first amino acid is γ-aminobutyric acid, and the second amino acid is at least one amino acid selected from taurine, leucine, phenylalanine, methionine, lysine, glycine, cysteine, and serine.
[0040] Furthermore, by adopting such a composition, it is possible to function together with the vitamins and minerals that are components of the other sleep-inducing aid composition to steadily promote the sleep disorder improving effect of cannabidiol.
[0041] The mineral constituting the sleep-inducing aid composition is at least one selected from potassium, calcium, magnesium, iron, and zinc, and is preferably contained in a proportion of 0.2 to 15 parts by weight per 100 parts by weight of the food for improving sleep. By using such a composition, it can function together with vitamins and amino acids, which are other components of the sleep-inducing aid composition, to steadily promote the sleep disorder improving effect of cannabidiol.
[0042] The sleep-improving food according to this embodiment will be further described below with reference to actual production examples and the results of effectiveness confirmation tests.
[0043] [1] Efficacy confirmation test for basic formula (1) Manufacturing of foods to help improve sleep 0.005 parts by weight of cannabidiol was mixed with 0.01 parts by weight of vitamin B6 as a sleep-inducing aid composition, 0.1 parts by weight of gamma-aminobutyric acid (0.01 parts by weight of taurine and a calcium preparation for food additives (0.01 parts by weight of calcium) constituting minerals, and 1.865 parts by weight of starch as a base material to prepare a mixed powder, which was then formed into a tablet to provide the sleep-improving food A1 of this embodiment. 2 g of the sleep-improving food A1 contains 0.005 g of cannabidiol, 0.01 g of vitamin B6, 0.1 g of gamma-aminobutyric acid, 0.01 g of taurine, and 0.01 g of calcium. Note that although starch is used in the production of this sleep-improving food, agar or the like may be added depending on the nature of the food, such as a soft capsule, hard capsule, jelly, gummy candy, liquid, etc.
[0044] For comparison, the following comparative foods X1 to X7 were also prepared. Comparative foods X1 to X7 were produced using the same manufacturing method as sleep-improving food A1, but some ingredients were omitted. The formulations of sleep-improving food A1 and comparative foods X1 to X7 are shown in Table 1 below. In addition, the comparative foods X1 to X7 were adjusted to a specified food weight (2 g) using starch for the formulation.
[0045] [Table 1]
[0046] Specifically, the comparative food X1 contains 0.005 g of cannabidiol per 2 g of the food, and compared to the obesity improvement food A1, it does not contain any of the sleep-inducing aids such as vitamin B6, γ-aminobutyric acid, taurine, or calcium.
[0047] Comparative food X2 contains 0.005 g of cannabidiol and 0.01 g of vitamin B6 per 2 g of food, and compared to sleep-improving food A1, it does not contain gamma-aminobutyric acid, taurine, and calcium, which constitute the sleep-inducing composition.
[0048] Comparative food X3 contains 0.005 g of cannabidiol, 0.01 g of vitamin B6, 0.1 g of γ-aminobutyric acid, and 0.01 g of taurine per 2 g of food, and compared to sleep-improving food A1, it does not contain calcium, which is a component of the sleep-inducing aid composition.
[0049] Comparative food X4 contains 0.005 g of cannabidiol, 0.01 g of vitamin B6, and 0.01 g of calcium per 2 g of food, and compared to sleep-improving food A1, it does not contain gamma-aminobutyric acid and taurine, which are components of the sleep-inducing composition.
[0050] Comparative food X5 contains 0.005 g of cannabidiol, 0.1 g of γ-aminobutyric acid, and 0.01 g of taurine per 2 g of food, and compared to sleep-improving food A1, it does not contain vitamin B6 and calcium, which are components of the sleep-inducing composition.
[0051] Comparative food X6 contains 0.005 g of cannabidiol, 0.1 g of γ-aminobutyric acid, 0.01 g of taurine, and 0.01 g of calcium per 2 g of food, and compared to sleep-improving food A1, it does not contain vitamin B6, which is a component of the sleep-inducing aid composition.
[0052] Comparative food X7 contains 0.005 g of cannabidiol and 0.01 g of calcium per 2 g of food, and compared to sleep-improving food A1, it does not contain vitamin B6, γ-aminobutyric acid, and taurine, which are components of the sleep-inducing composition.
[0053] (2) Human testing Next, regarding the sleep-improving food A1 according to this embodiment, a human test was conducted to confirm whether the inclusion of the sleep-inducing aid composition enhances the sleep disorder improving effect of cannabidiol.
[0054] The subjects were men and women in their 20s to 50s, with six people (three men and three women) in the group taking sleep-improving food A1 (hereinafter referred to as the test A1 group), six people (three men and three women) in the group taking comparative food X1 (hereinafter referred to as the comparative X1 group), six people (three men and three women) in the group taking comparative food X2 (hereinafter referred to as the comparative X2 group), six people (three men and three women) in the group taking comparative food X3 (hereinafter referred to as the comparative X3 group), and six people (three men and three women) in the group taking comparative food X4. Six people (three men and three women) were randomly assigned to the group that took the comparative food X5 (hereinafter referred to as the comparative group X5), six people (three men and three women) were randomly assigned to the group that took the comparative food X6 (hereinafter referred to as the comparative group X6), and six people (three men and three women) were randomly assigned to the group that took the comparative food X7 (hereinafter referred to as the comparative group X7), with three people randomly assigned to each of the 24 men and 24 women recruited. In the following explanation, the comparative groups X1 to X7 are also collectively referred to as the comparative groups.
[0055] For the test group A1, each subject was asked to take 2g of the sleep-improving food A1 in a tablet containing the amount of each ingredient shown in Table 1 after dinner for 12 weeks. Similarly, for the comparison group, each subject was asked to take 2g of one of the corresponding comparison foods X1 to X7 in a tablet containing the amount of each ingredient shown in Table 1 after dinner for 12 weeks.
[0056] The main symptoms of sleep disorders include taking a long time to actually fall asleep after getting into a sleep position, such as by lying down in bed (so-called difficulty falling asleep), or waking up in the middle of the night because one is unable to maintain sleep. In this study, the promotion effect of improving sleep disorders was confirmed by the subjects' subjective evaluation according to the Athens Insomnia Scale (AIS). Each subject was required to answer questions about their sleep state at least before the start of the study, and after 4 weeks, 8 weeks, and 12 weeks according to the Athens Insomnia Scale (AIS). In addition, the subjects were informed that during the study period, they could continue living the same lifestyle as before the study began.
[0057] The Athens Insomnia Scale (AIS) responses collected from each subject were used to calculate the average value for each measurement item, and the average values at each time point were subjected to the prescribed statistical processing. The test results are shown in Figure 1. The horizontal axis of the graph shows each time point: before the start of the test, after 4 weeks, 8 weeks, and 12 weeks, and the vertical axis shows the change value. In addition, on the Athens Insomnia Scale (AIS), the higher the score for each measurement item, the higher the possibility of insomnia. For this reason, in the graph shown in the figure, the larger the negative change value, the more the sleep state can be evaluated as having improved.
[0058] First, of the three functional ingredients of cannabidiol and the sleep-inducing composition, vitamin (vitamin B6), amino acids (γ-aminobutyric acid and taurine), and minerals (calcium), the comparative food X1 group, which contained only cannabidiol, showed a gradual effect of improving sleep.
[0059] In addition, among the functional components of cannabidiol, the comparative group X2, which took comparative food X2 containing vitamin B6, the comparative group X3, which took comparative food X3 containing vitamin B6, gamma-aminobutyric acid and taurine, the comparative group X4, which took comparative food X4 containing vitamin B6 and calcium, the comparative group X5, which took comparative food X5 containing gamma-aminobutyric acid and taurine, the comparative group X6, which took comparative food X6 containing gamma-aminobutyric acid, taurine and calcium, and the comparative group X7, which took comparative food X7 containing calcium, showed a gradual improvement tendency similar to that of the comparative group X1.
[0060] The tendency of sleep disorders to improve in these comparative groups X1 to X7 was probably caused by the sleep disorder improving effect that cannabidiol originally has. In addition, since comparative groups X2 to X7 showed the same behavior as comparative group X1, the promoting effect of cannabidiol on improving sleep disorders could not be confirmed when vitamins (vitamin B6), amino acids (γ-aminobutyric acid and taurine), and minerals (calcium) were used alone, or when two of the three functional ingredients were selected.
[0061] On the other hand, the test group A1 (black circle), who ingested the sleep-improving food A1, which contains cannabidiol and all three functional ingredients of the sleep-inducing aid composition, vitamin (vitamin B6), amino acids (γ-aminobutyric acid and taurine), and mineral (calcium), showed significant differences in changes in sleep state compared to each of the comparison groups X1 to X7, especially during the 12th week.
[0062] This indicates that the sleep-inducing composition contained in the sleep-improving food product A1 according to this embodiment enhances the sleep disorder improving effect of cannabidiol.
[0063] This indicates that the vitamin B6, the first amino acid gamma-aminobutyric acid, the second amino acid taurine, and the mineral calcium act synergistically to function as a sleep-inducing aid composition, thereby enhancing the sleep disorder-improving effect of cannabidiol.
[0064] [2] Effect verification test when the content ratio is changed Next, to what extent the sleep disorder improving effect is induced when the contents of cannabidiol, vitamins, amino acids, and minerals in the sleep disorder improving food are changed, several comparative foods were prepared based on the sleep onset improving food B1, and each was examined. Note that compared to the sleep onset improving food A1, sleep onset improving food B1 contains one-fifth the amount of cannabidiol (0.001g), one-fifth the amount of vitamin B6 (0.002g), the same amount of gamma-aminobutyric acid (0.1g), one-fifth the amount of taurine (0.002g), and two-fifths the amount of calcium (0.004g).
[0065] (1) Manufacturing food to improve sleep to examine cannabidiol content The two types of foods that have different cannabidiol contents based on the sleep-improving food B1 are the comparative foods C1 and C2 shown in Table 1. The comparative foods C1 and C2 contain 200 and 300 times the amount of cannabidiol, respectively, of the sleep-improving food B1. [Table 2]
[0066] (2) Confirmation of the effect of changing the amount of cannabidiol (human testing) Next, the sleep disorder improving effect was confirmed by having subjects take the sleep onset improving food B1 and the sleep onset improving food C1 and C2. The test method was the same as the above-mentioned "(1) Effect confirmation test with basic formula", and six subjects, three males and three females, were assigned to each group: a group taking the sleep onset improving food B1 (hereinafter referred to as the test B1 group), a group taking the comparative food C1 (hereinafter referred to as the comparative C1 group), and a group taking the comparative food C2 (hereinafter referred to as the comparative C2 group). Each subject was made to take the food for 12 weeks, and responses to the "Athens Insomnia Scale (AIS)" were collected from each subject before the start of the test and at a specified time point during the test period. The results are shown in Figure 2. The vertical and horizontal axes of the graph in Figure 2 are the same as those in Figure 1. The graph in Figure 2 also shows the results of the comparative group 1 (black triangles) taking the comparative food X1 that does not contain the sleep-inducing auxiliary composition in Table 1. In the following description, comparative groups C1 and C2, like comparative groups X1 to X7, are also collectively referred to as comparative groups.
[0067] As shown in Figure 2, the test B1 group, the comparative C1 group that ingested the comparative food C1 containing 200 times (0.2g) the amount of cannabidiol as the food for improving sleep B1, and the comparative C2 group that ingested the comparative food C2 containing 300 times (0.3g) the amount of cannabidiol as the food for improving sleep B1, showed roughly the same behavior as the test B1 group that ingested the food for improving sleep B1. No difference was observed in the effect of improving sleep onset between the comparative C1 group and the comparative C2 group. A significant difference was observed in the change in sleep state between the comparative C1 group and the comparative C2 group and the comparative X1 group, especially at the 12th week.
[0068] In addition, the change values of the comparative C1 group and the comparative C2 group were more negative than those of the comparative 1 group, which was given the comparative food X1 that did not contain a sleep-inducing composition. In other words, it was shown that the sleep-inducing composition containing the three ingredients of minerals, amino acids, and vitamins promoted the sleep disorder improving effect of cannabidiol.
[0069] (3) Manufacturing food to improve sleep and examine vitamin content The foods that have different vitamin B6 contents are based on Food for Improving Sleepiness B1 and are the three types of comparison foods V1, V2, and V3 shown in Table 3. Note that Food for Improving Sleepiness B1 in this table is Food for Improving Sleepiness B1 in Table 2, and the comparison foods V1, V2, and V3 have vitamin B6 contents that are varied from half the amount of Food for Improving Sleepiness B1 to 150 times the amount.
[0070] [Table 3]
[0071] (4) Confirmation of the promoting effect when the vitamin content is changed (human test) Next, we confirmed whether the sleep disorder improving effect would be promoted by having the subjects take the above-mentioned sleep onset improving food B1 and the comparative foods V1, V2, and V3. The test method was the same as that of the above-mentioned "(1) Effect confirmation test with basic formula", and six subjects, three males and three females, were assigned to each group, which took the comparative food V1 (hereinafter referred to as the comparative group V1), the comparative food V2 (hereinafter referred to as the comparative group V2), and the comparative food V3 (hereinafter referred to as the comparative group V3). Each subject took the food for 12 weeks, and records of the Athens Insomnia Scale (AIS) responses were collected from each subject before the start of the test and at specified points during the test period. The results are shown in Figure 3. The vertical and horizontal axes of the graph in Figure 3 are the same as those in Figure 1. 3 also shows the results of Comparative Group X1 (black triangles) who ingested Comparative Food X1, which does not contain the sleep-inducing composition in Table 1. In the following explanation, Comparative Groups V1 to V3 are also collectively referred to as Comparative Groups, just like Comparative Groups X1 to X7.
[0072] As shown in Figure 3, the comparative V1 group, which took comparative food V1 containing 100 times (0.2g) of vitamin B6 as compared with the sleep-improving food B1, and the comparative V2 group, which took comparative food V2 containing 150 times (0.3g) of vitamin B6 as compared with the sleep-improving food B1, showed roughly the same behavior as the test B1 group, which took the sleep-improving food B1. There was no difference in the sleep-improving effect between the comparative V1 group and the comparative V2 group. There was a significant difference in the change in sleep state between the comparative V1 group and the comparative V2 group and the comparative X1 group, especially at the 12th week.
[0073] In addition, in the comparative V3 group, which took comparative food V3 containing half the amount of vitamin B6 (0.001g) of the sleep-improving food B1, a gradual tendency for improvement in sleep state was observed before and after taking comparative food V3, but the change was smaller than that of comparative V1 and comparative V2 groups. The change in sleep state of comparative V2 group showed a behavior closer to that of comparative X1 group, which took comparative food X1 without a sleep-inducing composition, than that of subject B1 group. In other words, it was shown that the sleep-inducing composition containing a predetermined amount or more of vitamins, minerals, and amino acids promotes the sleep disorder improving effect of cannabidiol.
[0074] (5) Manufacturing food for improving sleep to examine the content of the first amino acid The three types of foods, comparative foods a1, a2, and a3, shown in Table 4, were created by varying the content of gamma-aminobutyric acid, the first amino acid, based on sleep onset improving food B1. Note that sleep onset improving food B1 in this table is sleep onset improving food B1 in Tables 2 and 3, and comparative foods a1, a2, and a3 have gamma-aminobutyric acid contents that are varied from one-fifth to five times the amount of sleep onset improving food B1.
[0075] [Table 4]
[0076] (6) Confirmation of the promoting effect when the content of the first amino acid is changed (human test) Next, it was confirmed whether the sleep disorder improving effect was induced by having subjects take the above-mentioned sleep onset improving food B1 and comparative foods a1, a2, and a3. The test method was the same as that of the above-mentioned "(1) Effect confirmation test with basic formula", and six subjects, three males and three females, were assigned to each group, which was to take comparative food a1 (hereinafter referred to as comparative group a1), comparative food a2 (hereinafter referred to as comparative group a2), and comparative food a3 (hereinafter referred to as comparative group a3). Each subject was made to take the food for 12 weeks, and responses to the "Athens Insomnia Scale (AIS)" were collected from each subject before the start of the test and at a predetermined time point during the test period. The results are shown in Figure 4. The vertical and horizontal axes of the graph in Figure 4 are the same as those in Figure 1. The graph in Figure 4 also shows the results of comparative group 1 (black triangles) that took comparative food X1, which does not contain the sleep-inducing composition in Table 1. In the following description, comparative groups a1 to a3, like comparative groups X1 to X7, are also collectively referred to as comparative groups.
[0077] As shown in Figure 4, the comparative a1 group, which ingested comparative food a1 containing 4 times (0.4g) the amount of gamma-aminobutyric acid as the sleep-improving food B1, and the comparative a2 group, which ingested comparative food a2 containing 5 times (0.5g) the amount of gamma-aminobutyric acid as the sleep-improving food B1, showed approximately the same behavior as the test B1 group, which ingested the sleep-improving food B1. No difference was observed in the sleep-improving effect between the comparative a1 group and the comparative a2 group. There was a significant difference in the change in sleep state between the comparative a1 group and the comparative a2 group and the comparative X1 group, especially at the 12th week.
[0078] In addition, the comparative group a3, which ingested comparative food a3 containing 1 / 5 the amount (0.02g) of gamma-aminobutyric acid in the sleep-improving food B1, showed a gradual tendency to improve the changes in sleep state, but the changes were smaller than those in the comparative groups a1 and a2. The changes in the sleep state of the comparative group a3 were closer to those of the comparative group X1, which ingested comparative food X1 that did not contain a sleep-inducing composition, than those of the subject group B1. In other words, it was shown that the sleep-inducing composition containing a predetermined amount or more of vitamins, minerals, and amino acids promotes the sleep disorder improving effect of cannabidiol.
[0079] (7) Manufacturing of food for improving sleep to examine the content of the second amino acid The three foods shown in Table 5 are comparative foods aa1, aa2, and aa3, which are based on the sleep onset improving food B1 but have different contents of taurine, the second amino acid. Note that the sleep onset improving food B1 in this table is the sleep onset improving food B1 in Tables 2 to 4, and the taurine contents of the comparative foods aa1, a2, and aa3 are varied from 1 / 10th to 150 times that of the sleep onset improving food B1.
[0080] [Table 5]
[0081] (8) Confirmation of the promoting effect when the content of the second amino acid is changed (human test) Next, it was confirmed whether the sleep disorder improving effect was induced by having the subjects take the above-mentioned sleep onset improving food B1 and the comparative foods aa1, aa2, and aa3. The test method was the same as that of the above-mentioned "(1) Effect confirmation test with basic formula", and six subjects, three males and three females, were assigned to each group, which was to take the comparative food aa1 (hereinafter referred to as the comparative aa1 group), the comparative food aa2 (hereinafter referred to as the comparative aa2 group), and the comparative food aa3 (hereinafter referred to as the comparative aa3 group). Each subject was made to take the food for 12 weeks, and the Athens Insomnia Scale (AIS) responses were collected from each subject before the start of the test and at a specified time point during the test period. The results are shown in Figure 5. The vertical and horizontal axes of the graph in Figure 5 are the same as those in Figure 1. The graph in FIG. 5 also shows the results for Comparative Group 1 (black triangles), which was administered Comparative Food X1 in Table 1, which does not contain the sleep-inducing composition.
[0082] As shown in Figure 5, the comparative aa1 group, which took the comparative food aa1 containing 120 times the amount (0.24g) of taurine as the food for improving sleep B1, and the comparative aa2 group, which took the comparative food aa2 containing 150 times the amount (0.3g) of taurine as the food for improving sleep B1, showed approximately the same behavior as the test B1 group, which took the food for improving sleep B1. There was no difference in the effect of improving sleep onset between the comparative aa1 group and the comparative aa2 group. There was a significant difference in the change in sleep state between the aa1 group and the comparative aa2 group and the comparative X1 group, especially at the 12th week.
[0083] In addition, the comparative aa3 group, which took the comparative food aa3 containing 1 / 10 the amount of taurine (0.0002g) of the food B1 for improving sleep, showed a gradual improvement in the changes in sleep state, but the changes were smaller than those of the comparative aa1 and aa2 groups. The changes in the sleep state of the comparative aa3 group were closer to those of the comparative X1 group, which took the comparative food X1 without the sleep-inducing composition, than those of the subject B1 group. In other words, it was shown that the sleep-inducing composition containing a predetermined amount or more of vitamins, minerals, and amino acids promoted the sleep disorder improving effect of cannabidiol.
[0084] (9) Manufacturing of sleep-improving foods to examine mineral content The three foods shown in Table 6 are comparative foods M1, M2, and M3, which are based on food for improving sleep onset B1 but have different calcium contents, a mineral component. Note that food for improving sleep onset B1 in this table is food for improving sleep onset B1 in Tables 2 to 5, and comparative foods M1, M2, and M3 have calcium contents that vary from half the amount of food for improving sleep onset B1 to 100 times the amount.
[0085] [Table 6]
[0086] (10) Confirmation of the promoting effect when changing mineral content Next, it was confirmed whether the sleep disorder improving effect was induced by having subjects take the above-mentioned sleep onset improving food B1 and comparative foods M1, M2, and M3. The test method was the same as that of the above-mentioned "(1) Effect confirmation test with basic formula", and six subjects, three males and three females, were assigned to each group, which was to take comparative food M1 (hereinafter referred to as comparative M1 group), comparative food M2 (hereinafter referred to as comparative M2 group), and comparative food M3 (hereinafter referred to as comparative M3 group). Each subject was made to take the food for 12 weeks, and responses to the "Athens Insomnia Scale (AIS)" were collected from each subject before the start of the test and at a predetermined time point during the test period. The results are shown in Figure 6. The vertical and horizontal axes of the graph in Figure 6 are the same as those in Figure 1. The graph in Figure 6 also shows the results of comparative group X1 (black triangles) which was made to take comparative food X1, which does not contain the sleep-inducing composition in Table 1.
[0087] As shown in Figure 6, the comparative M1 group (open circle) that ingested comparative food M1 containing 75 times (0.3g) the amount of calcium as food B1 for improving sleep onset, and the comparative M2 group (open square) that ingested comparative food M2 containing 100 times (0.4g) the amount of calcium as food B1 for improving sleep onset, showed roughly the same behavior as the test B1 group that ingested food B1 for improving sleep onset. No difference was observed in the sleep onset improvement effect between the comparative M1 group and the comparative M2 group. A significant difference was observed in the change in sleep state between the comparative M1 group and the comparative M2 group and the comparative X1 group, especially at the 12th week.
[0088] In addition, in the comparative M3 group, which took comparative food M3 containing half the amount of calcium (0.002g) of the food for improving sleep B1, a gradual tendency for improvement in sleep state was observed before and after taking comparative food M3, but the change was smaller than that of comparative M1 and comparative M2 groups. The change in sleep state of comparative M3 group showed a behavior closer to that of comparative X1 group, which took comparative food X1 without a sleep-inducing composition, than that of subject B1 group. In other words, it was shown that the sleep-inducing composition containing a predetermined amount or more of vitamins, minerals, and amino acids promotes the sleep disorder improving effect of cannabidiol.
[0089] Finally, the above-mentioned embodiments are merely examples of the present invention, and the present invention is not limited to the above-mentioned embodiments. Therefore, even if the above-mentioned embodiments are different, various modifications can be made depending on the design, etc., as long as they do not deviate from the technical idea of the present invention.
Claims
1. Cannabidiol and A sleep-inducing auxiliary composition that promotes the sleep disorder improving effect of the cannabidiol, The sleep-inducing composition comprises vitamins, amino acids, and minerals, The vitamin is vitamin B6 contained in 100 parts by weight of the food for improving sleep in an amount of 0.1 to 10 parts by weight, the amino acid comprises a first amino acid which is gamma-aminobutyric acid and is contained in an amount of 5 to 20 parts by weight per 100 parts by weight of the food for improving sleep, and a second amino acid which is taurine and is contained in an amount of 0.1 to 12 parts by weight per 100 parts by weight of the food for improving sleep, The food for improving sleep, wherein the mineral is calcium contained in an amount of 0.2 to 15 parts by weight per 100 parts by weight of the food for improving sleep.
2. 2. The food for improving sleep according to claim 1, characterized in that the cannabidiol is contained in an amount of 0.05 to 10 parts by weight per 100 parts by weight of the food for improving sleep.
3. 3. The food for improving sleep according to claim 1 or 2, characterized in that the food is in the form of a powder, fine granules, granules, soft capsules, hard capsules, jelly, gummy candy, liquid or tablet.
Citation Information
Patent Citations
Composition for releasing stress or for improving sleep disorder which contains fermented substance of mixture of oyster and seaweeds as active ingredient, and method of manufacturing the same
JP2014047213A
Hemp seed oil and brown algae derived health food
JP2017079615A
Vigor and / or vitality improver that uses GABA as active ingredient
JP2018020972A
Oral composition and food containing the same
JP2020182384A
Xu Fang's sleep aid drug system
JP2020525549A
